List of Excipients in API estradiol and norethindrone acetate
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing estradiol and norethindrone acetate
Detailed excipient profiles for estradiol and norethindrone acetate
Excipient focus: COPOVIDONE
estradiol and norethindrone acetate drug variants containing COPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | estradiol and norethindrone acetate | 54868-4677 |
| >Company | >Ingredient | >NDC |
estradiol and norethindrone acetate drug variants not containing COPOVIDONE
Excipient focus: COPOVIDONE K25-31
estradiol and norethindrone acetate drug variants containing COPOVIDONE K25-31
estradiol and norethindrone acetate drug variants not containing COPOVIDONE K25-31
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | estradiol and norethindrone acetate | 54868-4677 |
| Aurobindo Pharma Limited | estradiol and norethindrone acetate | 59651-425 |
| >Company | >Ingredient | >NDC |
Excipient focus: D&C YELLOW NO. 10
estradiol and norethindrone acetate drug variants containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| Ingenus Pharmaceuticals LLC | estradiol and norethindrone acetate | 50742-657 |
| >Company | >Ingredient | >NDC |
estradiol and norethindrone acetate drug variants not containing D&C YELLOW NO. 10
Excipient focus: FD&C BLUE NO. 2
estradiol and norethindrone acetate drug variants containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| Ingenus Pharmaceuticals LLC | estradiol and norethindrone acetate | 50742-657 |
| >Company | >Ingredient | >NDC |
estradiol and norethindrone acetate drug variants not containing FD&C BLUE NO. 2
Excipient focus: FD&C RED NO. 40
estradiol and norethindrone acetate drug variants containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Ingenus Pharmaceuticals LLC | estradiol and norethindrone acetate | 50742-657 |
| >Company | >Ingredient | >NDC |
estradiol and norethindrone acetate drug variants not containing FD&C RED NO. 40
Excipient focus: FD&C YELLOW NO. 6
estradiol and norethindrone acetate drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | estradiol and norethindrone acetate | 0378-7294 |
| >Company | >Ingredient | >NDC |
estradiol and norethindrone acetate drug variants not containing FD&C YELLOW NO. 6
Excipient focus: HYDROXYPROPYL CELLULOSE
estradiol and norethindrone acetate drug variants containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | estradiol and norethindrone acetate | 59651-425 |
| >Company | >Ingredient | >NDC |
estradiol and norethindrone acetate drug variants not containing HYDROXYPROPYL CELLULOSE
Excipient focus: HYPROMELLOSE
estradiol and norethindrone acetate drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Breckenridge Pharmaceutical Inc | estradiol and norethindrone acetate | 51991-474 |
| Naari Pte Limited | estradiol and norethindrone acetate | 79929-012 |
| >Company | >Ingredient | >NDC |
estradiol and norethindrone acetate drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE 2910
estradiol and norethindrone acetate drug variants containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | estradiol and norethindrone acetate | 0093-5455 |
| Aurobindo Pharma Limited | estradiol and norethindrone acetate | 59651-425 |
| >Company | >Ingredient | >NDC |
estradiol and norethindrone acetate drug variants not containing HYPROMELLOSE 2910
Excipient focus: HYPROMELLOSES
estradiol and norethindrone acetate drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | estradiol and norethindrone acetate | 54868-4677 |
| Lupin Pharmaceuticals Inc | estradiol and norethindrone acetate | 68180-830 |
| >Company | >Ingredient | >NDC |
estradiol and norethindrone acetate drug variants not containing HYPROMELLOSES
Excipient focus: LACTOSE MONOHYDRATE
estradiol and norethindrone acetate drug variants containing LACTOSE MONOHYDRATE
estradiol and norethindrone acetate drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: LECITHIN, SOYBEAN
estradiol and norethindrone acetate drug variants containing LECITHIN, SOYBEAN
| Company | Ingredient | NDC |
|---|---|---|
| Ingenus Pharmaceuticals LLC | estradiol and norethindrone acetate | 50742-657 |
| >Company | >Ingredient | >NDC |
estradiol and norethindrone acetate drug variants not containing LECITHIN, SOYBEAN
Excipient focus: MAGNESIUM STEARATE
estradiol and norethindrone acetate drug variants containing MAGNESIUM STEARATE
estradiol and norethindrone acetate drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 3350
estradiol and norethindrone acetate drug variants containing POLYETHYLENE GLYCOL 3350
| Company | Ingredient | NDC |
|---|---|---|
| Ingenus Pharmaceuticals LLC | estradiol and norethindrone acetate | 50742-657 |
| >Company | >Ingredient | >NDC |
estradiol and norethindrone acetate drug variants not containing POLYETHYLENE GLYCOL 3350
Excipient focus: POLYETHYLENE GLYCOL 400
estradiol and norethindrone acetate drug variants containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | estradiol and norethindrone acetate | 0093-5455 |
| >Company | >Ingredient | >NDC |
estradiol and norethindrone acetate drug variants not containing POLYETHYLENE GLYCOL 400
Excipient focus: POLYSORBATE 80
estradiol and norethindrone acetate drug variants containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | estradiol and norethindrone acetate | 0093-5455 |
| Ingenus Pharmaceuticals LLC | estradiol and norethindrone acetate | 50742-657 |
| Naari Pte Limited | estradiol and norethindrone acetate | 79929-012 |
| >Company | >Ingredient | >NDC |
estradiol and norethindrone acetate drug variants not containing POLYSORBATE 80
Excipient focus: POLYVINYL ALCOHOL
estradiol and norethindrone acetate drug variants containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Ingenus Pharmaceuticals LLC | estradiol and norethindrone acetate | 50742-657 |
| >Company | >Ingredient | >NDC |
estradiol and norethindrone acetate drug variants not containing POLYVINYL ALCOHOL
Excipient focus: SILICON DIOXIDE
estradiol and norethindrone acetate drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | estradiol and norethindrone acetate | 0093-5455 |
| >Company | >Ingredient | >NDC |
estradiol and norethindrone acetate drug variants not containing SILICON DIOXIDE
Excipient focus: STARCH, CORN
estradiol and norethindrone acetate drug variants containing STARCH, CORN
estradiol and norethindrone acetate drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
estradiol and norethindrone acetate drug variants containing TALC
estradiol and norethindrone acetate drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | estradiol and norethindrone acetate | 0093-5455 |
| Lupin Pharmaceuticals Inc | estradiol and norethindrone acetate | 68180-830 |
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
estradiol and norethindrone acetate drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | estradiol and norethindrone acetate | 0093-5455 |
| Ingenus Pharmaceuticals LLC | estradiol and norethindrone acetate | 50742-657 |
| >Company | >Ingredient | >NDC |
estradiol and norethindrone acetate drug variants not containing TITANIUM DIOXIDE
Excipient focus: TRIACETIN
estradiol and norethindrone acetate drug variants containing TRIACETIN
estradiol and norethindrone acetate drug variants not containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | estradiol and norethindrone acetate | 0093-5455 |
| Mylan Pharmaceuticals Inc | estradiol and norethindrone acetate | 0378-7294 |
| Ingenus Pharmaceuticals LLC | estradiol and norethindrone acetate | 50742-657 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
